Shona Banda cured her terminal Crohn’s disease with cannabis

Posted on May 24, 2014 by David

Image result for shona banda

“Shona Banda was diagnosed with Crohn’s disease… She underwent several surgeries and was put on several pharmaceuticals, but her condition worsened progressively until she was considered terminal. She was bedridden… wasting away… She was waiting to die.

She managed to see Rick Simpson’s Run from the Cure…”

“RUN FROM THE CURE: The Rick Simpson Story – A Film by Christian Laurette” https://www.youtube.com/watch?v=aGjC4HReFL0

“Although she had been smoking marijuana to ease pain and help her sleep and eat, she had no way of making the oil, which required a pound of marijuana to produce the two ounces of cannabis oil she would need to heal.

Shona was in a funk about the lack of enough hemp to make her own oil when her husband noticed specks of oil residue in the inside of the vaporizer’s glass globe cover.

So she took the inhalation tube out of the vaporizer and sealed it, then simply collected those little blobs of oil from the inside of the glass globe with a spatula.

She did this three times a day, putting the collected oil residue into a capsule and taking it. After a very few days, Shona could walk without a cane. Soon she began eating and sleeping better and putting on weight. It wasn’t long before she was completely weened off all her pharmaceuticals.

She started a journal as she began getting better. The journal has become a book called Live Free or Die. The title is a reference to health freedom. Now she is very healthy and active.”

http://www.naturalnews.com/043718_chrons_disease_cannabis_shona_banda.html

“Crohn’s Disease Survivor Shona Banda Tells How Medical Marijuana Oil Helps Her “Live Free”” https://www.youtube.com/watch?v=x_otUB7pVMA

“Ben Swann Radio: Shona Banda Explains Her Remarkable Story On How Cannabis Oil Saved Her Life. After being diagnosed with Crohn’s disease in 2002, Shona Banda went through the struggles that many suffer with when battling the autoimmune disease. On the Ben Swann Radio Show, Ben and Shona discussed her tribulations while suffering from the disease and her immediate experiences after finding the cure to her disease.”
http://benswann.com/ben-swann-radio-shona-banda-explains-her-remarkable-story-on-how-cannabis-oil-saved-her-life/#ixzz32d6WqrPM

https://www.facebook.com/shona.banda

https://www.facebook.com/pages/Shona-Bandas-Live-Free-or-Die/146496222049591

http://www.thctotalhealthcare.com/category/crohns-disease/

Cannabis Proves Effective In Treating Crohn’s Disease According To New Study

Posted on May 20, 2014 by David

cannibis crohn's disease drug

“A new clinical study published in the journal Pharmacology and by the National Institute of Health has found that cannabis is effective in treating Crohn’s disease, which is a form of inflammatory bowel disease (IBD)…

The study, entitled: “Cannabis Finds Its Way into Treatment of Crohn’s Disease” is co-authored by Rudolf Schicho, PhD and M. Storr, both of the Institute of Experimental and Clinical Pharmacology, Medical University of Graz in Graz, Austria.

In the study abstract, Schicho and Storr note that In ancient medicine, cannabis was widely used to treat and cure bowel disturbances and inflammation, and a recent clinical study now shows that the medicinal herb Cannabis sativa lived up to expectations and proved to be highly efficient in cases of inflammatory bowel diseases.”

http://bionews-tx.com/news/2014/01/29/cannabis-proves-effective-treating-crohns-disease-according-new-study/

http://www.thctotalhealthcare.com/category/crohns-disease/

Cannabis Finds Its Way into Treatment of Crohn’s Disease.

Posted on December 21, 2013 by David

“In ancient medicine, cannabis has been widely used to cure disturbances and inflammation of the bowel. A recent clinical study now shows that the medicinal plant Cannabis sativa has lived up to expectations and proved to be highly efficient in cases of inflammatory bowel diseases.

In a prospective placebo-controlled study, it has been shown what has been largely anticipated from anecdotal reports, i.e. that cannabis produces significant clinical benefits in patients with Crohn’s disease. The mechanisms involved are not yet clear but most likely include peripheral actions on cannabinoid receptors 1 and 2, and may also include central actions.”

http://www.ncbi.nlm.nih.gov/pubmed/24356243

“In their prospective study, Naftali et al. used THC-free Cannabis as placebo with no other cannabinoids present. However, we should consider that also other ingredients of Cannabis, such as cannabidiol, cannabigerol, and tetrahydrocannabivarine (THCV), all of them non-psychotropic components of Cannabis, have proven antiinflammatory effects in experimental intestinal inflammation. Their actions partly involve non-CB receptor mechanisms via, for instance, peroxisome proliferator-activated receptors (PPAR) and transient receptor potential cation channels subfamily V receptors (TRPV) and should be regarded as additive beneficial effects of Cannabis in the improvement of colitis in addition to THC-mediated effects.

…an 8-week treatment with THC-rich Cannabis caused a decrease of the Crohn’s disease activity index (CDAI) in 90% of patients without producing significant side effects…

In summary, in agreement with the ancient use of Cannabis in intestinal disturbances and one decade of animal research, Cannabis was shown in a clinical trial to reduce symptoms in patients with CD. This elegant translation should be followed by larger trials confirming these results and by trials establishing the involved mechanisms to open a promising direction for future treatment of IBD.”

Full-text: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076530/

Therapeutic potential of cannabinoid medicines.

Posted on September 6, 2013 by David

Drug Testing and Analysis

“Cannabis was extensively used as a medicine throughout the developed world in the nineteenth century but went into decline early in the twentieth century ahead of its emergence as the most widely used illicit recreational drug later that century. Recent advances in cannabinoid pharmacology alongside the discovery of the endocannabinoid system (ECS) have re-ignited interest in cannabis-based medicines.

The ECS has emerged as an important physiological system and plausible target for new medicines. Its receptors and endogenous ligands play a vital modulatory role in diverse functions including immune response, food intake, cognition, emotion, perception, behavioural reinforcement, motor co-ordination, body temperature, wake/sleep cycle, bone formation and resorption, and various aspects of hormonal control. In disease it may act as part of the physiological response or as a component of the underlying pathology.

In the forefront of clinical research are the cannabinoids delta-9-tetrahydrocannabinol and cannabidiol, and their contrasting pharmacology will be briefly outlined. The therapeutic potential and possible risks of drugs that inhibit the ECS will also be considered. This paper will then go on to review clinical research exploring the potential of cannabinoid medicines in the following indications: symptomatic relief in multiple sclerosis, chronic neuropathic pain, intractable nausea and vomiting, loss of appetite and weight in the context of cancer or AIDS, psychosis, epilepsy, addiction, and metabolic disorders.”

http://www.ncbi.nlm.nih.gov/pubmed/24006213

http://onlinelibrary.wiley.com/doi/10.1002/dta.1529/abstract

Medical Marijuana Achieves ‘Complete Remission’ Of Crohn’s Disease; Drug Improves Appetite And Sleep Function, With No Side Effects

Posted on July 24, 2013 by David

“Smoking medical marijuana achieved remission in five of 11 subjects with Crohn’s disease who smoked twice a day for eight weeks, as part of a study.”

Crohn’s disease, one of several inflammatory bowel diseases, achieved “complete remission” in nearly half the subjects of one study that were exposed to smoking medical marijuana on a regular basis.

Published in the journal Clinical Gastroenterology and Hepatology, the study examined the effects of consistent marijuana use on Crohn’s patients who suffered from severe cases of the disease. The results of the 21-subject study point toward the drug’s anti-inflammatory properties as being responsible for quieting symptoms in many patients, and even reaching total remission in others.”

More: http://www.medicaldaily.com/articles/17529/20130718/medical-marijuana-crohns-disease-remission-anti-inflammatory-drug-inflammatory-bowel-disease.htm

“Study: Marijuana May Achieve Complete Remission of Crohn’s Disease” http://blog.mpp.org/research/study-marijuana-may-achieve-complete-remission-of-crohns-disease/07192013/

“Cannabis Induces a Clinical Response in Patients with Crohn’s Disease: a Prospective Placebo-Controlled Study... The marijuana plant Cannabis sativa has been reported to produce beneficial effects for patients with inflammatory bowel diseases… We performed a prospective trial to determine whether cannabis can induce remission in patients with Crohn’s disease…Complete remission was achieved by 5/11 subjects in the cannabis group…Three patients in the cannabis group were weaned from steroid dependency . Subjects receiving cannabis reported improved appetite and sleep, with no significant side effects.” http://www.ncbi.nlm.nih.gov/pubmed/23648372

Marijuana: Miracle Cure For Crohn’s Disease?

Posted on July 23, 2013 by David

“Crohn’s disease is a autoimmunity deficiency in the gastronomical tract that can cause anything from mild stomach pains to vomiting and in extreme cases, chronic bloody diarrhea. There’s no cure for the disorder but now, researchers in Israel say they’ve found evidence that marijuana causes complete remission of the disease.

This news comes the Meir Medical Center in Israel, which treated 21 patients suffering from Crohn’s disease. 11 of the patients smoked two joints per day of cannabis sativa, which the researchers believed would provide anti-inflammatory relief, while the other (unlucky) 10 were only given a placebo. “The marijuana plant Cannabis sativa has been reported to produce beneficial effects for patients with inflammatory bowel diseases, but this has not been investigated in controlled trials,” the researchers argued. “We performed a prospective trial to determine whether cannabis can induce remission in patients with Crohn’s disease.”

Five of the 11 patients who smoked the weed, the study, which was published in the U.S. National Library of Medicine, states, acheived “total remission” of their disease, whereas only four of the 10 patients who didn’t smoke the pot reported only slight improvement of their condition. Needless to say, the study, while promising, only seems to suggest that more research should be undertaken. “Further studies, with larger patient groups and a nonsmoking mode of intake, are warranted,” the scientists argued.”

http://blogs.ocweekly.com/navelgazing/2013/07/marijuana_miracle_cure_for_cro.php

The endocannabinoid system and its therapeutic exploitation.

Posted on May 24, 2013 by David

Image result for Nat Rev Drug Discov.

“The term ‘endocannabinoid’ – originally coined in the mid-1990s after the discovery of membrane receptors for the psychoactive principle in Cannabis, Delta9-tetrahydrocannabinol and their endogenous ligands – now indicates a whole signalling system that comprises cannabinoid receptors, endogenous ligands and enzymes for ligand biosynthesis and inactivation. This system seems to be involved in an ever-increasing number of pathological conditions. With novel products already being aimed at the pharmaceutical market little more than a decade since the discovery of cannabinoid receptors, the endocannabinoid system seems to hold even more promise for the future development of therapeutic drugs. We explore the conditions under which the potential of targeting the endocannabinoid system might be realized in the years to come.” http://www.ncbi.nlm.nih.gov/pubmed/15340387

http://www.nature.com/nrd/journal/v3/n9/full/nrd1495.html

Marijuana might be able to treat your terrible case of the runs – MSN

Posted on May 23, 2013 by David

“Seems there’s no end to the list of maladies medical marijuana can’t treat.”

“The latest: diarrhea, the awful affliction that sounds like “dire rear” for a reason. According to the pot aficionados behind The Weed Blog (who mightn’t be the most unbiased sources on the matter), cannabis-derived products have been used to treat diarrhea in India since at least the late 1800s. These products reportedly cause diarrhea and its symptoms to subside, and — surprise, surprise — help patients regain their appetites. Around 3.5 million people die from diarrhea and its nasty effects every year, so these alleged benefits of pot aren’t just useful to stoners who could fake the runs to score a medical marijuana prescription.”

http://now.msn.com/medical-marijuana-might-treat-diarrhea

Marijuana is an Effective Treatment for Crohn’s Disease

Posted on May 23, 2013 by David

“A study published earlier this month on the government’s website National Institutes of Health found that marijuana has “significant benefits” for treating Crohn’s Disease and Irritable Bowel Syndrome (IBS).

“A short course (8 week) of THC-rich cannabis produced significant clinical, steroid-free benefits to 11 patients with active CD, compared to placebo, without side effects,” the study concluded.”

Study Suggests Marijuana Mitigates Symptoms Of Crohn’s Disease

Posted on May 23, 2013 by David

“Treatment through cannabis may be beneficial to patients with Crohn’s disease, new research finds.

More and more, researchers are investigating the beneficial effects of marijuana on a variety of diseases. In Clinical Gastroenterology and Hepatology this week, researchers in Israel reported their findings from a study of how cannabis affects patients with Crohn’s disease.

Cannabis sativa has been reported to benefit inflammatory bowel diseases, the researchers wrote. The team wanted to see if it was possible to induce remission in Crohn’s patients through cannabis treatment…

… a short course (8 weeks) of THC-rich cannabis produced significant clinical, steroid-free benefits to 11 patients with active CD, compared to placebo, without side effects,” the team wrote. “Further studies, with larger patient groups and a non-smoking mode of intake, are warranted.”